NDC 70518-3213-01 - Doxycycline Hyclate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70518-3213
- Requested NDC
- 70518-3213-01
- Package NDCs from labels
- 70518-3213-0, 70518-3213-1, 70518-3213-2, 70518-3213-4, 70518-3213-3, 70518-3213-5, 70518-3213-6, 70518-3213-7, 70518-3213-8, 70518-3213-9, 70518-3213-01
- Manufacturer
- REMEDYREPACK INC.
- Effective date
- 2026-10-02
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Doxycycline Hyclate - REMEDYREPACK INC. | REMEDYREPACK INC. | 2026-10-02 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70518-3213-0 | Doxycycline Hyclate | 14 in 1 BOTTLE, PLASTIC | TABLET, FILM COATED | 14 | 16 | |
| 70518-3213-1 | Doxycycline Hyclate | 14 in 1 BOTTLE, PLASTIC | TABLET, FILM COATED | 14 | 16 | |
| 70518-3213-2 | Doxycycline Hyclate | 60 in 1 BOTTLE, PLASTIC | TABLET, FILM COATED | 60 | 16 | |
| 70518-3213-3 | Doxycycline Hyclate | 2 in 1 BOX | TABLET, FILM COATED | 2 | 16 | |
| 70518-3213-4 | Doxycycline Hyclate | 1 in 1 POUCH | TABLET, FILM COATED | 1 | 16 | |
| 70518-3213-5 | Doxycycline Hyclate | 20 in 1 BOTTLE, PLASTIC | TABLET, FILM COATED | 20 | 16 | |
| 70518-3213-6 | Doxycycline Hyclate | 10 in 1 BOTTLE, PLASTIC | TABLET, FILM COATED | 10 | 16 | |
| 70518-3213-7 | Doxycycline Hyclate | 20 in 1 BOTTLE, PLASTIC | TABLET, FILM COATED | 20 | 16 | |
| 70518-3213-8 | Doxycycline Hyclate | 28 in 1 BOTTLE, PLASTIC | TABLET, FILM COATED | 28 | 16 | |
| 70518-3213-9 | Doxycycline Hyclate | 56 in 1 BOTTLE, PLASTIC | TABLET, FILM COATED | 56 | 16 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70518-3213 | DOXYCYCLINE HYCLATE TABLET, FILM COATED [REMEDYREPACK INC.] | 10 | Current NDC, Legacy NDC, 10 package rows | 20250502_c8194d6e-c407-465e-a342-4d2d9756dfc4.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | Alembic Pharmaceuticals Inc. | 7c33c1b8-100e-4df8-be8d-de3eed7ced94 | 2025-04-30 | Warnings, Adverse reactions | 19XTS3T51U |
| No7 Lift and Luminate Triple Action Serum Foundation Sunscreen Broad Spectrum SPF 15 Porcelain | OCTINOXATE, TITANIUM DIOXIDE | BCM Cosmetique SAS | 2fbf7f9d-dba7-48f9-b10e-63225e8f1399 | 2025-04-25 | Warnings | 15FIX9V2JP |
| Algenist | OCTINOXATE, TITANIUM DIOXIDE, ZINC OXIDE | Solazyme, Inc. | 4ece1847-1c94-4bf7-b936-109556a460a7 | 2025-04-22 | Warnings | 15FIX9V2JP |
| Sulwhasoo Perfecting Cushion NO.17N1 Vanilla | OCTINOXATE, TITANIUM DIOXIDE, AND HOMOSALATE | Amorepacific Corporation | 3350f28e-22b4-904c-e063-6394a90a1c81 | 2025-04-21 | Warnings | 15FIX9V2JP |
| DOXYCYCLINE HYCLATE | DOXYCYCLINE HYCLATE | Alembic Pharmaceuticals Inc. | cec4368f-2852-443d-9d6f-7ba95807021b | 2025-04-16 | Warnings, Adverse reactions | 19XTS3T51U |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | Chartwell RX, LLC | b3294889-e8f8-42f1-9bd0-13d87572997a | 2025-04-15 | Warnings, Adverse reactions | 19XTS3T51U |
| Cicapair Soothing Color Correcting Treatment Cica Complex Broad Spectrum SPF 30 | TITANIUM DIOXIDE AND ZINC OXIDE | Have & Be Co., Ltd. | 32c1aba6-5e29-aba9-e063-6394a90a8e56 | 2025-04-14 | Warnings | 15FIX9V2JP |
| REPAIRWEAR UPLIFTING FIRMING BROAD SPECTRUM SPF 15 DRY | OCTINOXATE, OCTISALATE, AND TITANIUM DIOXIDE | CLINIQUE LABORATORIES LLC | 07701e11-8a7e-44c5-b46e-5b48264eacad | 2025-04-14 | Warnings | 15FIX9V2JP |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS | 65cac0b6-3550-48cf-bffa-cf42443c2731 | 2025-04-14 | Warnings, Adverse reactions | 1650143 19XTS3T51U |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | Mayne Pharma Commercial LLC | cd2ab9b8-9619-4199-8a5d-83377b3274d1 | 2025-04-14 | Warnings, Adverse reactions | 19XTS3T51U |
| Smoothing Mineral Sunscreen Tinted | TITANIUM DIOXIDE, ZINC OXIDE | DANIEL BEHROOZAN MD A MEDICAL CORPORATION | 327246c2-9d7a-2d34-e063-6294a90a5fb7 | 2025-04-10 | 15FIX9V2JP | |
| Clarity Rx Physical Skin Defense SPF 50 | ZINC OXIDE AND TITANIUM DIOXIDE | Topiderm, Inc. | b5111012-97b9-4908-95a0-d09595f9c4d9 | 2025-04-10 | Warnings | 15FIX9V2JP |
| Tinted Mineral Sunscreen SPF 50 | ZINC OXIDE AND TITANIUM DIOXIDE | Topiderm, Inc. | 13e5085f-df2b-46b2-b063-e58ce4379905 | 2025-04-09 | Warnings | 15FIX9V2JP |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | Coupler LLC | 325d5331-d48e-1bc4-e063-6394a90a65b9 | 2025-04-09 | Warnings, Adverse reactions | 1649405 19XTS3T51U |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | Sun Pharmaceutical Industries, Inc. | bff3f426-44fc-4dbf-96df-df44011103e8 | 2025-04-03 | Warnings, Adverse reactions | 19XTS3T51U |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | Epic Pharma, LLC | 2b402587-8ecc-4fea-83ad-8071345b6356 | 2025-04-01 | Warnings, Adverse reactions | 1650143 19XTS3T51U |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | Actavis Pharma, Inc. | c2b08332-3256-4658-965a-ede3d973a388 | 2025-04-01 | Warnings, Adverse reactions | 19XTS3T51U |
| DOXYCYCLINE | DOXYCYCLINE | FOSUN PHARMA USA INC | fa3fbb09-b830-60c5-e053-6394a90a4165 | 2025-04-01 | Warnings, Adverse reactions | 19XTS3T51U |
| City Skin Age Defense Broad Spectrum SPF 50 | TITANIUM DIOXIDE AND ZINC OXIDE | Murad, LLC | f8c572a2-b4bc-49e9-95df-359f05bd69b7 | 2025-03-28 | Warnings | 15FIX9V2JP |
| DOXYCYCLINE HYCLATE | DOXYCYCLINE HYCLATE | Bryant Ranch Prepack | e726157e-ce44-4df3-8161-7016700dd751 | 2025-03-27 | Warnings, Adverse reactions | 1650143 19XTS3T51U |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.